Most cited papers in Male Breast Health Studies
What are the most cited papers in Male Breast Health Studies?
The most cited paper in Male Breast Health Studies is "Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial" (Writing Group for the Women's Health Initiative Investigators, 2002), with 15,961 citations. Next come "Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer" (13,212) and "Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer" (2,868).
Showing 50 of 99 papers. Every paper with more than 379 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial Writing Group for the Women's Health Initiative Investigators · JAMA | 17 Jul 2002 | 15,961 |
| 2 | Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer Reiki Nishimura, Tomofumi Osako, Yasuyuki Nishiyama et al. · Oncology | 2013 | 13,212 |
| 3 | Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer José Baselga et al. · New England Journal of Medicine | 7 Dec 2011 | 2,868 |
| 4 | Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial Bertran Auvert, Dirk Taljaard, Emmanuel Lagarde et al. · PLoS Medicine | 18 Oct 2005 | 2,469 |
| 5 | Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes Umberto Veronesi, Giovanni Paganelli, Viviana Enrica Galimberti et al. · The Lancet | Jun 1997 | 1,942 |
| 6 | Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis Armando E. Giuliano, Karla V. Ballman, Linda Mackie McCall et al. · JAMA | 12 Sep 2017 | 1,941 |
| 7 | Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. Bernard Fisher, Ashley E. Brown, E.P. Mamounas et al. · Journal of Clinical Oncology | Jul 1997 | 1,816 |
| 8 | Endogenous Sex Hormones and Breast Cancer in Postmenopausal Women: Reanalysis of Nine Prospective Studies The Endogenous Hormones and Breast Cancer Collaborative Group · JNCI Journal of the National Cancer Institute | 17 Apr 2002 | 1,803 |
| 9 | The Diagnosis and Treatment of Prostate Cancer Mark S. Litwin, Hung‐Jui Tan · JAMA | 27 Jun 2017 | 1,479 |
| 10 | Reanalysis and Results after 12 Years of Follow-up in a Randomized Clinical Trial Comparing Total Mastectomy with Lumpectomy with or without Irradiation in the Treatment of Breast Cancer Bernard Fisher, Stewart Anderson, Carol K. Redmond et al. · New England Journal of Medicine | 30 Nov 1995 | 1,475 |
| 11 | Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343 Kevin S. Hughes, Lauren A. Schnaper, Jennifer Ruth Bellon et al. · Journal of Clinical Oncology | 21 May 2013 | 1,319 |
| 12 | Major Causes of Death among Men and Women in China Jiang He, Dongfeng Gu, Xigui Wu et al. · New England Journal of Medicine | 14 Sep 2005 | 1,153 |
| 13 | Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17 Paul Edward Goss, James N. Ingle, Silvana Martino et al. · JNCI Journal of the National Cancer Institute | 6 Sep 2005 | 1,124 |
| 14 | Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer Bruce George Haffty, Qifeng Yang, Michael Reiß et al. · Journal of Clinical Oncology | 21 Nov 2006 | 1,122 |
| 15 | Sentinel lymphadenectomy in breast cancer. A. E. Giuliano, Ronald Coy Jones, Murray F. Brennan et al. · Journal of Clinical Oncology | Jun 1997 | 1,106 |
| 16 | Body Mass Index, Serum Sex Hormones, and Breast Cancer Risk in Postmenopausal Women Endogenous Hormones Breast Cancer Collaborative Group · JNCI Journal of the National Cancer Institute | 19 Aug 2003 | 1,100 |
| 17 | Cancer Incidence in BRCA1 Mutation Carriers Douglas Thompson · JNCI Journal of the National Cancer Institute | 17 Sep 2002 | 1,099 |
| 18 | Lumpectomy plus Tamoxifen with or without Irradiation in Women 70 Years of Age or Older with Early Breast Cancer Kevin S. Hughes, Lauren A. Schnaper, Donald A. Berry et al. · New England Journal of Medicine | Sep 2004 | 1,084 |
| 19 | Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300 000 women in US SEER cancer registries Sarah C. Darby, Paul McGale, Carolyn W. Taylor et al. · The Lancet Oncology | 6 Jul 2005 | 1,056 |
| 20 | Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial Bernard Fisher, James J. Dignam, Norman Wolmark et al. · The Lancet | Jun 1999 | 1,045 |
| 21 | Breast Cancer after Prophylactic Bilateral Mastectomy in Women with aBRCA1orBRCA2Mutation Hanne Meijers-Heijboer, Bert van Geel, Wim L.J. van Putten et al. · New England Journal of Medicine | 19 Jul 2001 | 966 |
| 22 | Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE Nasim Mavaddat et al. · JNCI Journal of the National Cancer Institute | Apr 2013 | 951 |
| 23 | Benign Breast Disease and the Risk of Breast Cancer Lynn C. Hartmann, Thomas A. Sellers, Marlene Hanson Frost et al. · New England Journal of Medicine | 20 Jul 2005 | 951 |
| 24 | MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer Constance Dobbins Lehman, Constantine A. Gatsonis, Christiane Katharina Kuhl et al. · New England Journal of Medicine | 28 Mar 2007 | 945 |
| 25 | Improved Axillary Staging of Breast Cancer with Sentinel Lymphadenectomy Armando E. Giuliano, Paul S. Dale, Roderick R. Turner et al. · Annals of Surgery | Sep 1995 | 937 |
| 26 | Lifetime Cancer Risks in Individuals with GermlinePTENMutations Min-Han Tan, Jessica L. Mester, Joanne Yuen Yie Ngeow et al. · Clinical Cancer Research | 15 Jan 2012 | 900 |
| 27 | National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000 National Institutes of Health Consensus Development Panel · JNCI Journal of the National Cancer Institute | 4 Jul 2001 | 900 |
| 28 | Annual Report to the Nation on the Status of Cancer, 1975-2000, Featuring the Uses of Surveillance Data for Cancer Prevention and Control Hannah K. Weir · JNCI Journal of the National Cancer Institute | 2 Sep 2003 | 868 |
| 29 | Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them Paul Linh Nguyen, Shabbir M.H. Alibhai, Shehzad Basaria et al. · European Urology | 2 Aug 2014 | 842 |
| 30 | Breast carcinoma in men Sharon Hermes Giordano, Deborah S. Cohen, Aman U. Buzdar et al. · Cancer | 24 May 2004 | 794 |
| 31 | Male breast cancer Ian S. Fentiman, Alain Fourquet, Gabriel N. Hortobágyi · The Lancet | Feb 2006 | 743 |
| 32 | Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer Donald A. Berry, Constance Cirrincione, I. Craig Henderson et al. · JAMA | 11 Apr 2006 | 732 |
| 33 | Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review Caitlin C. Murphy, Leona Kay Bartholomew, Melissa Y. Carpentier et al. · Breast Cancer Research and Treatment | 11 Jun 2012 | 730 |
| 34 | Competing Risk Analysis of Men Aged 55 to 74 Years at Diagnosis Managed Conservatively for Clinically Localized Prostate Cancer Peter C. Albertsen · JAMA | 16 Sep 1998 | 729 |
| 35 | Tamoxifen, Radiation Therapy, or Both for Prevention of Ipsilateral Breast Tumor Recurrence After Lumpectomy in Women With Invasive Breast Cancers of One Centimeter or Less Bernard Fisher, John Bryant, James J. Dignam et al. · Journal of Clinical Oncology | 11 Oct 2002 | 697 |
| 36 | Plasma Sex Steroid Hormone Levels and Risk of Breast Cancer in Postmenopausal Women Susan E. Hankinson, Walter Churchill Willett, JoAnn E. Manson et al. · JNCI Journal of the National Cancer Institute | 2 Sep 1998 | 693 |
| 37 | Sentinel Lymph Node Biopsy in Breast Cancer: Guidelines and Pitfalls of Lymphoscintigraphy and Gamma Probe Detection Paul J. Borgstein, Rik J. Pijpers, Emile F.I. Comans et al. · Journal of the American College of Surgeons | Mar 1998 | 692 |
| 38 | BRCA1Mutations in Women Attending Clinics That Evaluate the Risk of Breast Cancer Fergus J. Couch, Michelle L. DeShano, M. Anne Blackwood et al. · New England Journal of Medicine | 15 May 1997 | 683 |
| 39 | Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer William U. Shipley et al. · New England Journal of Medicine | Feb 2017 | 676 |
| 40 | Randomized Trial of Breast Irradiation Schedules After Lumpectomy for Women With Lymph Node-Negative Breast Cancer Timothy Joseph Whelan · JNCI Journal of the National Cancer Institute | 7 Aug 2002 | 673 |
| 41 | Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years Paul Edward Goss, James N. Ingle, Kathleen I. Pritchard et al. · New England Journal of Medicine | 5 Jun 2016 | 656 |
| 42 | Adult Weight Change and Risk of Postmenopausal Breast Cancer A. Heather Eliassen, Graham A. Colditz, BERNARD A. ROSNER et al. · JAMA | 11 Jul 2006 | 655 |
| 43 | Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk Marian L. Neuhouser, Aaron K. Aragaki, Ross L. Prentice et al. · JAMA Oncology | 11 Jun 2015 | 647 |
| 44 | Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Objective Measurements Sarah A. McLaughlin, Mary Jo Wright, Katherine Teresa Morris et al. · Journal of Clinical Oncology | 6 Oct 2008 | 645 |
| 45 | Contralateral Breast Cancer in BRCA1 and BRCA2 Mutation Carriers Kelly A. Metcalfe, Henry T. Lynch, Parviz Ghadirian et al. · Journal of Clinical Oncology | 15 Jun 2004 | 620 |
| 46 | Histopathologic Validation of the Sentinel Lymph Node Hypothesis for Breast Carcinoma Roderick R. Turner, David W. Ollila, David L. Krasne et al. · Annals of Surgery | Sep 1997 | 618 |
| 47 | Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes Beth A Virnig, Todd M. Tuttle, Tatyana Shamliyan et al. · JNCI Journal of the National Cancer Institute | 13 Jan 2010 | 615 |
| 48 | Preservation of Fertility in Patients with Cancer Jacqueline Sara Jeruss, Teresa K. Woodruff · New England Journal of Medicine | 25 Feb 2009 | 585 |
| 49 | Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. A. J. Nixon, Donna S Neuberg, Daniel F.C. Hayes et al. · Journal of Clinical Oncology | May 1994 | 584 |
| 50 | Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States) Libby M. Morimoto, Emily D. White, Z. Chen et al. · Cancer Causes & Control | Oct 2002 | 572 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.